Click here to open an external link.
ATTENTION:
You will be leaving CeQur’s website. CeQur does not control the content of the website you are visiting.
Recent Posts
- June, 2024CeQur Simplicity™, a Wearable Mealtime Insulin Delivery Device, Obtains FDA-Clearance for 4 Days of Wear to Further Simplify Diabetes Management
- June, 2021CeQur Appoints Rick Doubleday and Dr. Meret Gaugler to Board of Directors
- April, 2021CeQur Raises $115 Million Series C5
- June, 2020“High Treatment Satisfaction with 3-day Insulin Patch is Independent of Patient Demographics: A Post-Hoc Analysis” — a presentation at the American Diabetes Association 80th Scientific Sessions
- June, 2019The Wider View: With new CEO in place, CeQur primed to PAQ a punch in diabetes market